John Cavan
Directeur Général chez HEPION PHARMACEUTICALS, INC.
Fortune : 964 $ au 30/04/2024
Postes actifs de John Cavan
Sociétés | Poste | Début | Fin |
---|---|---|---|
HEPION PHARMACEUTICALS, INC. | Directeur Général | 04/12/2023 | - |
Directeur Financier/CFO | 01/01/2016 | - | |
Public Communications Contact | 01/01/2016 | - | |
Vantage Health System, Inc. | Directeur/Membre du Conseil | - | - |
Historique de carrière de John Cavan
Anciens postes connus de John Cavan
Sociétés | Poste | Début | Fin |
---|---|---|---|
AEGERION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 16/08/2010 | 01/02/2012 |
STEMLINE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/06/2006 | 01/02/2012 |
AlgoRx Pharmaceuticals, Inc.
AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AlgoRx Pharmaceuticals, Inc. was a pharmaceutical company. The company developed and commercialized drugs for pain management. The company was founded in 2001 and was hedquartered in Secaucus, NJ. | Comptroller/Controller/Auditor | 01/01/2004 | - |
Formation de John Cavan
Iona College | Undergraduate Degree |
Seton Hall University | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Comptroller/Controller/Auditor | 3 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
HEPION PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
AlgoRx Pharmaceuticals, Inc.
AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AlgoRx Pharmaceuticals, Inc. was a pharmaceutical company. The company developed and commercialized drugs for pain management. The company was founded in 2001 and was hedquartered in Secaucus, NJ. | Health Technology |
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY. | Health Technology |
Vantage Health System, Inc. |
- Bourse
- Insiders
- John Cavan
- Expérience